The event was organised in Tromsø by the University of Tromsø (UiT)s PYRO (Postdoctoral and Young Researcher Organization) and NCMM (Centre for Molecular Medicine Norway). The webinar took place on Thursday 23 September and saw researchers from university and hospital environments in Tromsø gather online to learn more about the different research infrastructures available to help support their research projects.
NCMM researchers featured
The webinar co-organiser, NCMM-based EATRIS coordinator, Anita Kavlie, presented EATRIS and its offerings to the research community, with Johannes Landskron, Head of the Chemical Biology Platform at NCMM, presenting the platform and the services that he and his team can offer researchers. NCMM's Director, Professor Janna Saarela ended the webinar with a summary of the event, highlighting the importance of infrastructures to research projects.
The programme was as follows:
13:00: PYRO, Erik Knutsen - Welcome and intro:
13:05 : Norseq, Ruth H Paulssen, Sequencing
13:15: PRiME, Sietske Grijseels - Proteomics and Metabolomics
13:25: Biobank Norway, Kristian Hveem - Biobank data
13:35: KAM /AMCF, Kenneth Bowitz Larsen - Advanced microscopy
13:45: Norbrain/viral core, Rajeevkumar R Nair - Viral vector tools for neuroscience and biomedicine
13:55: Short coffee break
14:10: Nor-Openscreen, Johannes Landskron - Chemical Biology, high throughput screening, bioprospecting
14:20: ELIXIR Norway, Christine Stansberg - Life science data
14:30: EATRIS Norway, Anita Kavlie, Translational research, EU funding application support
14:40: NorCRIN, Berit Gravrok/Ingvild Pettersen - Clinical trials
14:50: Janna Saarela, director NCMM - Conclusions, questions, and feedback
You can watch a recording of the webinar via the image below:
The seminar was possible with the help of EATRIS (European Infrastructure for Translational Medicine). EATRIS is a non-profit European Research Infrastructure Consortium (ERIC) that focuses on preclinical and early clinical development of medicinal products and diagnostics and provide solutions in five platforms of expertise, Advanced Therapy Medicinal Products (ATMPs), Biomarkers, Imaging and Tracing, Small Molecules and Vaccines.